[MDGL] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
09-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 11.18%
YoY- -35.09%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 770 0 0 0 0 0 0 -
PBT -112,194 -98,740 -85,800 -76,896 -85,905 -81,197 -70,730 35.89%
Tax 98 -135 3,425 896 1,682 1,502 780 -74.81%
NP -112,194 -98,740 -85,800 -77,792 -87,587 -82,699 -71,510 34.91%
Tax Rate - - - - - - - -
Total Cost 112,964 98,740 85,800 77,792 87,587 82,699 71,510 35.52%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -14,570.65 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -5.68 -5.34 -4.69 -4.28 -5.08 -4.84 -4.18 22.61%
EPS Diluted -5.68 -5.34 -4.69 -4.28 -5.08 -4.84 -4.18 22.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.